Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹59.90
Market cap
₹129.2 Cr
Revenue (annual)
₹23.73 Cr
Net profit (annual)
₹-16.93 Cr
P/E (TTM)
-9.2×Sector 47.4×
Promoter holding
72.74%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:28 IST BSE
Annual Report

Krebs Biochemicals & Industries Annual Report

Krebs Biochemicals & Industries Limited has submitted its 34th Annual Report for the financial year 2025-26. The report includes financial highlights, directors' report, and audited financial statements.